Viewing Study NCT06760260


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2025-12-27 @ 10:15 AM
Study NCT ID: NCT06760260
Status: RECRUITING
Last Update Posted: 2025-01-07
First Post: 2024-12-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: Hrain Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module